Grants per year
Personal profile
Research Interests
My clinical interests include primary brain and spinal cord tumors, metastatic tumors, and neurologic complications from cancer and its associated treatment. I have a special interest in central nervous system lymphoma and neuro-cutaneous disorders.
Training Experience
| 2012 | Internship, University of Illinois at Chicago |
| 2015 | Residency, University of Illinois at Chicago |
| 2016 | Fellowship, Northwestern University, McGaw Medical Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, Medicine, Louisiana State University
… → 2011
Research interests keywords
- Brain Cancer / Nervous System Cancer
- Neuro-Oncology
- Neurology
- Spinal Cord Tumors
Fingerprint
Dive into the research topics where Karan Dixit is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #CA-4948-101: An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Relapsed or Refractory Primary Central Nervous Sy
Dixit, K. (PD/PI)
Catalyst Clinical Research, LLC, Curis, Inc.
8/8/24 → 8/8/27
Project: Research project
-
Prot #ONC201-108: ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Dixit, K. (PD/PI)
PPD Investigator Services, LLC, Chimerix, Inc.
7/31/24 → 7/31/27
Project: Research project
-
A phase 1 adaptive dose escalation with dose expansion study of Triapine in combination with temozolomide (TMZ) for patients with recurrent glioblastoma
Dixit, K. (PD/PI)
7/1/24 → 6/30/25
Project: Research project
-
Prot #CL1-95032-005: A Phase 1, Safety Lead-in and Randomized, Open-label, Perioperative Study of Vorasidenib in Combination with Pembrolizumab in Subjects with Recurrent or Progressive Enhancing IDH-1 Mutant Astrocytomas
Dixit, K. (PD/PI) & Kumthekar, P. U. (PD/PI)
PPD Development, Servier Bio-Innovation LLC
5/22/23 → 5/22/26
Project: Research project
-
Levetiracetam and valproic acid in glioma: antiseizure and potential antineoplastic effects
Khalili, B. F., Walbert, T., Horbinski, C., Dixit, K., Gururangan, K., Thio, H., Tate, M. C., Stupp, R., Lukas, R. V. & Templer, J. W., 2025, In: Future Oncology. 21, 4, p. 483-491 9 p.Research output: Contribution to journal › Review article › peer-review
-
A Case Report of Systemic Lupus Erythematosus Presenting as Isolated Mononeuropathy Multiplex
Andreoli, M., Hollenhorst, C. N., Malavia, T., May, J. L., Priyadarshini, S., Seth, A. & Dixit, K., 2024, (Accepted/In press) In: Neurohospitalist.Research output: Contribution to journal › Article › peer-review
-
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma
Driscoll, R. K., Lyne, S. B., Voce, D. J., Maraka, S., Gondi, V., Chmura, S. J., Dixit, K. S., Kumthekar, P. U., Karrison, T. G., Pytel, P., Collins, J. M., Stupp, R., Merrell, R. T., Lukas, R. V. & Yamini, B., Jan 1 2024, In: Neuro-Oncology Advances. 6, 1, vdae014.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy
Dixit, K., Singer, L., Grimm, S. A., Lukas, R. V., Schwartz, M. A., Rademaker, A., Zhang, H., Kocherginsky, M., Chernet, S., Sharp, L., Nelson, V., Raizer, J. J. & Kumthekar, P., Jun 2024, In: Cancers. 16, 11, 2133.Research output: Contribution to journal › Article › peer-review
Open Access -
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians
Kumthekar, P., Lyleroehr, M., Lacson, L., Lukas, R. V., Dixit, K., Stupp, R., Kruser, T. J., Raizer, J. J., Hou, A., Sachdev, S., Schwartz, M., PA, J. B., Lezon, R., Schmidt, K., Amidei, C. & Kaiser Tegel, K. A., Dec 2024, In: BMC cancer. 24, 1, 527.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations